Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
September 30, 2026 -0.033M
June 30, 2026 0.00
March 31, 2026 0.00
December 31, 2025 0.00
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 0.00
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.289M
December 31, 2022 0.952M
September 30, 2022 1.437M
June 30, 2022 1.437M
March 31, 2022 1.148M
Date Value
December 31, 2021 0.485M
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 0.00
June 30, 2020 0.00
March 31, 2020 0.00
December 31, 2019 -0.525M
September 30, 2019 -0.991M
June 30, 2019 -1.331M
March 31, 2019 -1.697M
December 31, 2018 -1.528M
September 30, 2018 -1.431M
June 30, 2018 -1.406M
March 31, 2018 -1.04M
December 31, 2017 -0.684M
September 30, 2017 -0.315M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Q32 Bio, Inc. 53.39M
IRulya Therapeutics, Inc. -0.131M
Climb Bio, Inc. -0.296M
PepGen Inc. -1.155M
Bridgebio Oncology Therapeutics, Inc. -0.763M